Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 10;18(7):1485.
doi: 10.3390/ijms18071485.

Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments

Lai-San Wong  1 , Tiffany Wu  2 , Chih-Hung Lee  3
Affiliations
Review

Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments

Lai-San Wong et al. Int J Mol Sci. .

Abstract

Itch is the main chief complaint in patients visiting dermatologic clinics and has the ability to deeply impair life quality. Itch results from activation of cutaneous nerve endings by noxious stimuli such as inflammatory mediators, neurotransmitters and neuropeptides, causing itch signal transduction from peripheral skin, through the spinal cord and thalamus, to the brain cortex. Primarily noninflammatory diseases, such as uremic pruritus, cause itch through certain pruritogens in the skin. In inflammatory skin diseases, atopic dermatitis (AD) is the prototypic disease causing intensive itch by aberrant skin inflammation and epidermal barrier disruption. Recent understanding of disease susceptibility, severity markers, and mechanisms have helped to develop targeted therapy for itch in AD, including monoclonal antibodies against IL-4, IL-13, thymic stromal lymphopoietin (TSLP), IgE and IL-31. Promising effects have been observed in some of them. In this review, we summarized targeted therapies for inflammatory itch in AD and for managing abnormal itch transductions in other common itching skin diseases.

Keywords: atopic dermatitis; itch; pruritogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Stander S., Steinhoff M., Schmelz M., Weisshaar E., Metze D., Luger T. Neurophysiology of pruritus: Cutaneous elicitation of itch. Arch. Dermatol. 2003;139:1463–1470. doi: 10.1001/archderm.139.11.1463. - DOI - PubMed
    1. Ikoma A., Steinhoff M., Stander S., Yosipovitch G., Schmelz M. The neurobiology of itch. Nat. Rev. Neurosci. 2006;7:535–547. doi: 10.1038/nrn1950. - DOI - PubMed
    1. Sun Y.G., Chen Z.F. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007;448:700–703. doi: 10.1038/nature06029. - DOI - PubMed
    1. Liu X.Y., Liu Z.C., Sun Y.G., Ross M., Kim S., Tsai F.F., Li Q.F., Jeffry J., Kim J.Y., Loh H.H., et al. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell. 2011;147:447–458. doi: 10.1016/j.cell.2011.08.043. - DOI - PMC - PubMed
    1. Mishra S.K., Hoon M.A. The cells and circuitry for itch responses in mice. Science. 2013;340:968–971. doi: 10.1126/science.1233765. - DOI - PMC - PubMed